NCT04851821View on ClinicalTrials.gov

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

May 30, 2021

Study Completion Date

June 30, 2021

Conditions
a Randomized Double-blind StudySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)PHYTOTHERAPIE
Interventions
DRUG

Quercetin

Each patient included, after signing the consent, will have a treatment for ten days: one tablet times three per day 30 minutes before the meal.

Trial Locations (1)

Unknown

Riadh Boukef, Sahloul

All Listed Sponsors
lead

Hôpital Universitaire Sahloul

OTHER

NCT04851821 - The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | Biotech Hunter | Biotech Hunter